531
Views
0
CrossRef citations to date
0
Altmetric
Pulmonary Medicine

Melatonin mediates intestinal barrier dysfunction and systemic inflammation in moderate-severe OSA patients

, , , , , , & show all
Article: 2361825 | Received 11 Oct 2023, Accepted 21 May 2024, Published online: 08 Jul 2024

References

  • Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):1–12. doi: 10.1016/S2213-2600(19)30198-5.
  • Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–1014. doi: 10.1093/aje/kws342.
  • Yeghiazarians Y, Jneid H, Tietjens JR, et al. Obstructive sleep apnea and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;144(3):e56–e67. doi: 10.1161/CIR.0000000000000988.
  • Patel SR. Obstructive sleep apnea. Ann Intern Med. 2019;171(11):ITC81–ITC96. doi: 10.7326/AITC201912030.
  • Veasey SC, Rosen IM. Obstructive sleep apnea in adults. N Engl J Med. 2019;380(15):1442–1449. doi: 10.1056/NEJMcp1816152.
  • Maniaci A, Ferlito S, Lechien JR, et al. Anxiety, depression and sleepiness in OSA patients treated with barbed reposition pharyngoplasty: a prospective study. Eur Arch Otorhinolaryngol. 2022;279(8):4189–4198. doi: 10.1007/s00405-022-07369-9.
  • May AM, Van Wagoner DR, Mehra R. OSA and cardiac arrhythmogenesis: mechanistic insights. Chest. 2017;151(1):225–241. doi: 10.1016/j.chest.2016.09.014.
  • Nanduri J, Vaddi DR, Khan SA, et al. Xanthine oxidase mediates hypoxia-inducible factor-2α degradation by intermittent hypoxia. PLOS One. 2013;8(10):e75838. doi: 10.1371/journal.pone.0075838.
  • DeMartino T, Ghoul RE, Wang L, et al. Oxidative stress and inflammation differentially elevated in objective versus habitual subjective reduced sleep duration in obstructive sleep apnea. Sleep. 2016;39(7):1361–1369. doi: 10.5665/sleep.5964.
  • Laratta CR, Kendzerska T, Carlsten C, et al. Air pollution and systemic inflammation in patients with suspected OSA living in an urban residential area. Chest. 2020;158(4):1713–1722. doi: 10.1016/j.chest.2020.05.596.
  • McNicholas WT. COPD-OSA overlap syndrome: evolving evidence regarding epidemiology, clinical consequences, and management. Chest. 2017;152(6):1318–1326. doi: 10.1016/j.chest.2017.04.160.
  • Shamsuzzaman ASM, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105(21):2462–2464. doi: 10.1161/01.cir.0000018948.95175.03.
  • Moreno-Indias I, Torres M, Sanchez-Alcoholado L, et al. Normoxic recovery mimicking treatment of sleep apnea does not reverse intermittent hypoxia-induced bacterial dysbiosis and low-grade endotoxemia in mice. Sleep. 2016;39(10):1891–1897. doi: 10.5665/sleep.6176.
  • Kheirandish-Gozal L, Peris E, Wang Y, et al. Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity. J Clin Endocrinol Metab. 2014;99(2):656–663. doi: 10.1210/jc.2013-3327.
  • Barceló A, Esquinas C, Robles J, et al. Gut epithelial barrier markers in patients with obstructive sleep apnea. Sleep Med. 2016;26:12–15. doi: 10.1016/j.sleep.2016.01.019.
  • Badran M, Mashaqi S, Gozal D. The gut microbiome as a target for adjuvant therapy in obstructive sleep apnea. Expert Opin Ther Targets. 2020;24(12):1263–1282. doi: 10.1080/14728222.2020.1841749.
  • Li Q, Xu T, Shao C, et al. Obstructive sleep apnea is related to alterations in fecal microbiome and impaired intestinal barrier function. Sci Rep. 2023;13(1):778. doi: 10.1038/s41598-023-27784-0.
  • Heizati M, Li N, Shao L, et al. Does increased serum d-lactate mean subclinical hyperpermeability of intestinal barrier in middle-aged nonobese males with OSA? Medicine. 2017;96(49):e9144. doi: 10.1097/MD.0000000000009144.
  • Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc. 1958;80(10):2587. doi: 10.1021/ja01543a060.
  • Zhang YJ, Liu T, Yang HL, et al. Melatonin: a novel candidate for the treatment of osteoarthritis. Ageing Res Rev. 2022;78:101635. doi: 10.1016/j.arr.2022.101635.
  • Fernández-Mar MI, Mateos R, García-Parrilla MC, et al. Bioactive compounds in wine: resveratrol, hydroxytyrosol and melatonin: a review. Food Chem. 2012;130(4):797–813. doi: 10.1016/j.foodchem.2011.08.023.
  • Reiter RJ, Tan D-X, Rosales-Corral S, et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem. 2013;13(3):373–384. doi: 10.2174/1389557511313030006.
  • Ahmadi S, Taghizadieh M, Mehdizadehfar E, et al. Gut microbiota in neurological diseases: melatonin plays an important regulatory role. Biomed Pharmacother. 2024;174:116487. doi: 10.1016/j.biopha.2024.116487.
  • Majka J, Wierdak M, Brzozowska I, et al. Melatonin in prevention of the sequence from reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma: experimental and clinical perspectives. Int J Mol Sci. 2018;19(7):2033. doi: 10.3390/ijms19072033.
  • Barnaś M, Maskey-Warzęchowska M, Bielicki P, et al. Diurnal and nocturnal serum melatonin concentrations after treatment with continuous positive airway pressure in patients with obstructive sleep apnea. Pol Arch Intern Med. 2017;127(9):589–596. doi: 10.20452/pamw.4062.
  • Hung M-W, Kravtsov GM, Lau C-F, et al. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J Pineal Res. 2013;55(3):247–256. doi: 10.1111/jpi.12067.
  • Yeung H-M, Hung M-W, Lau C-F, et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J Pineal Res. 2015;58(1):12–25. doi: 10.1111/jpi.12190.
  • Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. Deliberations of the sleep apnea definitions task force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597–619. doi: 10.5664/jcsm.2172.
  • Chung KF. Use of the Epworth Sleepiness Scale in Chinese patients with obstructive sleep apnea and normal hospital employees. J Psychosom Res. 2000;49(5):367–372. doi: 10.1016/s0022-3999(00)00186-0.
  • Berry RB, Brooks R, Gamaldo C, et al. AASM scoring manual updates for 2017 (version 2.4). J Clin Sleep Med. 2017;13(5):665–666. doi: 10.5664/jcsm.6576.
  • Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40(3):879–891. doi: 10.3758/brm.40.3.879.
  • O’Connor C, Thornley KS, Hanly PJ. Gender differences in the polysomnographic features of obstructive sleep apnea. Am J Respir Crit Care Med. 2000;161(5):1465–1472. doi: 10.1164/ajrccm.161.5.9904121.
  • Huang S-H, Cao X-J, Wei W. Melatonin decreases TLR3-mediated inflammatory factor expression via inhibition of NF-kappa B activation in respiratory syncytial virus-infected RAW264.7 macrophages. J Pineal Res. 2008;45(1):93–100. doi: 10.1111/j.1600-079X.2008.00560.x.
  • Zhao M, Song X, Chen H, et al. Melatonin prevents chondrocyte matrix degradation in rats with experimentally induced osteoarthritis by inhibiting nuclear factor-κB via SIRT1. Nutrients. 2022;14(19):3966. doi: 10.3390/nu14193966.
  • Xin X, Liu J, Liu X, et al. Melatonin-derived carbon dots with free radical scavenging property for effective periodontitis treatment via the Nrf2/HO-1 pathway. ACS Nano. 2024;18(11):8307–8324. doi: 10.1021/acsnano.3c12580.
  • Prasad B, Nyenhuis SM, Imayama I, et al. Asthma and obstructive sleep apnea overlap: what has the evidence taught us? Am J Respir Crit Care Med. 2020;201(11):1345–1357. doi: 10.1164/rccm.201810-1838TR.
  • Drager LF, Togeiro SM, Polotsky VY, et al. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–576. doi: 10.1016/j.jacc.2013.05.045.
  • Sharma SK, Kumpawat S, Banga A, et al. Prevalence and risk factors of obstructive sleep apnea syndrome in a population of Delhi, India. Chest. 2006;130(1):149–156. doi: 10.1378/chest.130.1.149.
  • Kanbay M, Ureche C, Copur S, et al. Kidney transplantation: a possible solution to obstructive sleep apnea in patients with end-stage kidney disease. Sleep Breath. 2023;27(5):1667–1675. doi: 10.1007/s11325-023-02803-6.
  • Hoffman K, Mansoor E, Panhwar MS, et al. Prevalence of obstructive sleep apnea is increased in patients with inflammatory bowel disease: a large, multi-network study. Crohns Colitis 360. 2022;4(3):otac026. doi: 10.1093/crocol/otac026.
  • Sommerfeld A, Althouse AD, Prince J, et al. Obstructive sleep apnea is associated with increased readmission in heart failure patients. Clin Cardiol. 2017;40(10):873–878. doi: 10.1002/clc.22738.
  • Cho JH, Bhutani S, Kim CH, et al. Anti-inflammatory effects of melatonin: a systematic review and meta-analysis of clinical trials. Brain Behav Immun. 2021;93:245–253. doi: 10.1016/j.bbi.2021.01.034.
  • Akbari M, Ostadmohammadi V, Tabrizi R, et al. The effects of melatonin supplementation on inflammatory markers among patients with metabolic syndrome or related disorders: a systematic review and meta-analysis of randomized controlled trials. Inflammopharmacology. 2018;26(4):899–907. doi: 10.1007/s10787-018-0508-7.
  • Acuña-Castroviejo D, Escames G, Venegas C, et al. Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci. 2014;71(16):2997–3025. doi: 10.1007/s00018-014-1579-2.
  • Chojnacki C, Wisniewska-Jarosinska M, Walecka-Kapica E, et al. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J Physiol Pharmacol. 2011;62(3):327–334.
  • Gao T, Wang Z, Dong Y, et al. Role of melatonin in sleep deprivation-induced intestinal barrier dysfunction in mice. J Pineal Res. 2019;67(1):e12574. doi: 10.1111/jpi.12574.
  • Gooneratne NS, Gehrman P, Gurubhagavatula I, et al. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study. J Clin Sleep Med. 2010;6(6):572–580.
  • Gaspar LS, Hesse J, Yalçin M, et al. Long-term continuous positive airway pressure treatment ameliorates biological clock disruptions in obstructive sleep apnea. EBioMedicine. 2021;65:103248. doi: 10.1016/j.ebiom.2021.103248.
  • Miller MA, Cappuccio FP. A systematic review of COVID-19 and obstructive sleep apnoea. Sleep Med Rev. 2021;55:101382. doi: 10.1016/j.smrv.2020.101382.
  • Javaheri S, Javaheri S. Update on persistent excessive daytime sleepiness in OSA. Chest. 2020;158(2):776–786. doi: 10.1016/j.chest.2020.02.036.
  • Shah NM, Malhotra AM, Kaltsakas G. Sleep disorder in patients with chronic liver disease: a narrative review. J Thorac Dis. 2020;12(Suppl. 2):S248–S260. doi: 10.21037/jtd-cus-2020-012.
  • Bertuglia S, Reiter RJ. Melatonin reduces microvascular damage and insulin resistance in hamsters due to chronic intermittent hypoxia. J Pineal Res. 2009;46(3):307–313. doi: 10.1111/j.1600-079X.2008.00662.x.
  • Wang F, Zou J, Xu H, et al. Effects of chronic intermittent hypoxia and chronic sleep fragmentation on gut microbiome, serum metabolome, liver and adipose tissue morphology. Front Endocrinol. 2022;13:820939. doi: 10.3389/fendo.2022.820939.
  • Wang B, Zhu S, Liu Z, et al. Increased expression of colonic mucosal melatonin in patients with irritable bowel syndrome correlated with gut dysbiosis. Genomics Proteomics Bioinformatics. 2020;18(6):708–720. doi: 10.1016/j.gpb.2020.06.013.
  • Xu P, Wang J, Hong F, et al. Melatonin prevents obesity through modulation of gut microbiota in mice. J Pineal Res. 2017;62(4). doi: 10.1111/jpi.12399.
  • Zhang H-M, Zhang Y. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res. 2014;57(2):131–146. doi: 10.1111/jpi.12162.
  • Li X, Wang F, Gao Z, et al. Melatonin attenuates chronic intermittent hypoxia-induced intestinal barrier dysfunction in mice. Microbiol Res. 2023;276:127480. doi: 10.1016/j.micres.2023.127480.
  • Mashaqi S, Kallamadi R, Matta A, et al. Obstructive sleep apnea as a risk factor for COVID-19 severity—the gut microbiome as a common player mediating systemic inflammation via gut barrier dysfunction. Cells. 2022;11(9):1569. doi: 10.3390/cells11091569.
  • Maniaci A, Di Luca M, Lechien JR, et al. Lateral pharyngoplasty vs. traditional uvulopalatopharyngoplasty for patients with OSA: systematic review and meta-analysis. Sleep Breath. 2022;26(4):1539–1550. doi: 10.1007/s11325-021-02520-y.
  • Lv R, Liu X, Zhang Y, et al. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct Target Ther. 2023;8(1):218. doi: 10.1038/s41392-023-01496-3.